The Epithelial to Mesenchymal Transition in Colorectal Cancer Progression: The Emerging Role of Succinate Dehydrogenase Alterations and Succinate Accumulation

Colorectal cancer (CRC) stands as the third most significant contributor to cancer-related mortality worldwide. A major underlying reason is that the detection of CRC usually occurs at an advanced metastatic stage, rendering therapies ineffective. In the progression from the in situ neoplasia stage...

Full description

Bibliographic Details
Main Authors: Mimmo Turano, Rosario Vicidomini, Francesca Cammarota, Valeria D’Agostino, Francesca Duraturo, Paola Izzo, Marina De Rosa
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/5/1428
_version_ 1827741892331175936
author Mimmo Turano
Rosario Vicidomini
Francesca Cammarota
Valeria D’Agostino
Francesca Duraturo
Paola Izzo
Marina De Rosa
author_facet Mimmo Turano
Rosario Vicidomini
Francesca Cammarota
Valeria D’Agostino
Francesca Duraturo
Paola Izzo
Marina De Rosa
author_sort Mimmo Turano
collection DOAJ
description Colorectal cancer (CRC) stands as the third most significant contributor to cancer-related mortality worldwide. A major underlying reason is that the detection of CRC usually occurs at an advanced metastatic stage, rendering therapies ineffective. In the progression from the in situ neoplasia stage to the advanced metastatic stage, a critical molecular mechanism involved is the epithelial-to-mesenchymal transition (EMT). This intricate transformation consists of a series of molecular changes, ultimately leading the epithelial cell to relinquish its features and acquire mesenchymal and stem-like cell characteristics. The EMT regulation involves several factors, such as transcription factors, cytokines, micro RNAs and long noncoding RNAs. Nevertheless, recent studies have illuminated an emerging link between metabolic alterations and EMT in various types of cancers, including colorectal cancers. In this review, we delved into the pivotal role played by EMT during CRC progression, with a focus on highlighting the relationship between the alterations of the tricarboxylic acid cycle, specifically those involving the succinate dehydrogenase enzyme, and the activation of the EMT program. In fact, emerging evidence supports the idea that elucidating the metabolic modifications that can either induce or inhibit tumor progression could be of immense significance for shaping new therapeutic approaches and preventative measures. We conclude that an extensive effort must be directed towards research for the standardization of drugs that specifically target proteins such as SDH and SUCNR1, but also TRAP1, PDH, ERK1/2, STAT3 and the HIF1-α catabolism.
first_indexed 2024-03-11T03:54:33Z
format Article
id doaj.art-393cbc8f06484e9c96f41a50059ff7a3
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-11T03:54:33Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-393cbc8f06484e9c96f41a50059ff7a32023-11-18T00:36:57ZengMDPI AGBiomedicines2227-90592023-05-01115142810.3390/biomedicines11051428The Epithelial to Mesenchymal Transition in Colorectal Cancer Progression: The Emerging Role of Succinate Dehydrogenase Alterations and Succinate AccumulationMimmo Turano0Rosario Vicidomini1Francesca Cammarota2Valeria D’Agostino3Francesca Duraturo4Paola Izzo5Marina De Rosa6Department of Biology, University of Naples Federico II, 80126 Naples, ItalySection on Cellular Communication, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USADepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, ItalyColorectal cancer (CRC) stands as the third most significant contributor to cancer-related mortality worldwide. A major underlying reason is that the detection of CRC usually occurs at an advanced metastatic stage, rendering therapies ineffective. In the progression from the in situ neoplasia stage to the advanced metastatic stage, a critical molecular mechanism involved is the epithelial-to-mesenchymal transition (EMT). This intricate transformation consists of a series of molecular changes, ultimately leading the epithelial cell to relinquish its features and acquire mesenchymal and stem-like cell characteristics. The EMT regulation involves several factors, such as transcription factors, cytokines, micro RNAs and long noncoding RNAs. Nevertheless, recent studies have illuminated an emerging link between metabolic alterations and EMT in various types of cancers, including colorectal cancers. In this review, we delved into the pivotal role played by EMT during CRC progression, with a focus on highlighting the relationship between the alterations of the tricarboxylic acid cycle, specifically those involving the succinate dehydrogenase enzyme, and the activation of the EMT program. In fact, emerging evidence supports the idea that elucidating the metabolic modifications that can either induce or inhibit tumor progression could be of immense significance for shaping new therapeutic approaches and preventative measures. We conclude that an extensive effort must be directed towards research for the standardization of drugs that specifically target proteins such as SDH and SUCNR1, but also TRAP1, PDH, ERK1/2, STAT3 and the HIF1-α catabolism.https://www.mdpi.com/2227-9059/11/5/1428colorectal cancers (CRCs)epithelial to mesenchymal transition (EMT)succinate dehydrogenase (SDH)succinatemetabolic reprogramming
spellingShingle Mimmo Turano
Rosario Vicidomini
Francesca Cammarota
Valeria D’Agostino
Francesca Duraturo
Paola Izzo
Marina De Rosa
The Epithelial to Mesenchymal Transition in Colorectal Cancer Progression: The Emerging Role of Succinate Dehydrogenase Alterations and Succinate Accumulation
Biomedicines
colorectal cancers (CRCs)
epithelial to mesenchymal transition (EMT)
succinate dehydrogenase (SDH)
succinate
metabolic reprogramming
title The Epithelial to Mesenchymal Transition in Colorectal Cancer Progression: The Emerging Role of Succinate Dehydrogenase Alterations and Succinate Accumulation
title_full The Epithelial to Mesenchymal Transition in Colorectal Cancer Progression: The Emerging Role of Succinate Dehydrogenase Alterations and Succinate Accumulation
title_fullStr The Epithelial to Mesenchymal Transition in Colorectal Cancer Progression: The Emerging Role of Succinate Dehydrogenase Alterations and Succinate Accumulation
title_full_unstemmed The Epithelial to Mesenchymal Transition in Colorectal Cancer Progression: The Emerging Role of Succinate Dehydrogenase Alterations and Succinate Accumulation
title_short The Epithelial to Mesenchymal Transition in Colorectal Cancer Progression: The Emerging Role of Succinate Dehydrogenase Alterations and Succinate Accumulation
title_sort epithelial to mesenchymal transition in colorectal cancer progression the emerging role of succinate dehydrogenase alterations and succinate accumulation
topic colorectal cancers (CRCs)
epithelial to mesenchymal transition (EMT)
succinate dehydrogenase (SDH)
succinate
metabolic reprogramming
url https://www.mdpi.com/2227-9059/11/5/1428
work_keys_str_mv AT mimmoturano theepithelialtomesenchymaltransitionincolorectalcancerprogressiontheemergingroleofsuccinatedehydrogenasealterationsandsuccinateaccumulation
AT rosariovicidomini theepithelialtomesenchymaltransitionincolorectalcancerprogressiontheemergingroleofsuccinatedehydrogenasealterationsandsuccinateaccumulation
AT francescacammarota theepithelialtomesenchymaltransitionincolorectalcancerprogressiontheemergingroleofsuccinatedehydrogenasealterationsandsuccinateaccumulation
AT valeriadagostino theepithelialtomesenchymaltransitionincolorectalcancerprogressiontheemergingroleofsuccinatedehydrogenasealterationsandsuccinateaccumulation
AT francescaduraturo theepithelialtomesenchymaltransitionincolorectalcancerprogressiontheemergingroleofsuccinatedehydrogenasealterationsandsuccinateaccumulation
AT paolaizzo theepithelialtomesenchymaltransitionincolorectalcancerprogressiontheemergingroleofsuccinatedehydrogenasealterationsandsuccinateaccumulation
AT marinaderosa theepithelialtomesenchymaltransitionincolorectalcancerprogressiontheemergingroleofsuccinatedehydrogenasealterationsandsuccinateaccumulation
AT mimmoturano epithelialtomesenchymaltransitionincolorectalcancerprogressiontheemergingroleofsuccinatedehydrogenasealterationsandsuccinateaccumulation
AT rosariovicidomini epithelialtomesenchymaltransitionincolorectalcancerprogressiontheemergingroleofsuccinatedehydrogenasealterationsandsuccinateaccumulation
AT francescacammarota epithelialtomesenchymaltransitionincolorectalcancerprogressiontheemergingroleofsuccinatedehydrogenasealterationsandsuccinateaccumulation
AT valeriadagostino epithelialtomesenchymaltransitionincolorectalcancerprogressiontheemergingroleofsuccinatedehydrogenasealterationsandsuccinateaccumulation
AT francescaduraturo epithelialtomesenchymaltransitionincolorectalcancerprogressiontheemergingroleofsuccinatedehydrogenasealterationsandsuccinateaccumulation
AT paolaizzo epithelialtomesenchymaltransitionincolorectalcancerprogressiontheemergingroleofsuccinatedehydrogenasealterationsandsuccinateaccumulation
AT marinaderosa epithelialtomesenchymaltransitionincolorectalcancerprogressiontheemergingroleofsuccinatedehydrogenasealterationsandsuccinateaccumulation